Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Leonard

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Transgenic mice carrying intact HIV provirus: biological effects and organization of a transgeneJ W Abramczuk, D S Pezen, J M Leonard, et al.
Journal of Virology|August 8, 1998
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitorA Carrillo, K D Stewart, H L Sham, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavirA Hsu, G R Granneman, G Cao, et al.
Transplantation|September 1, 1983
Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantationJ E Sanders, C D Buckner, J M Leonard, et al.
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
Science (New York, N.Y.)|December 23, 1988
Development of disease and virus recovery in transgenic mice containing HIV proviral DNAJ M Leonard, J W Abramczuk, D S Pezen, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteersA Hsu, G R Granneman, G Cao, et al.
The New England Journal of Medicine|December 7, 1995
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infectionM Markowitz, M Saag, W G Powderly, et al.
The Journal of Infectious Diseases|April 16, 1998
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavirJ B Angel, A Kumar, K Parato, et al.
Journal of Virology|May 30, 1998
Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapyP S Eastman, J Mittler, R Kelso, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Transgenic mice carrying intact HIV provirus: biological effects and organization of a transgeneJ W Abramczuk, D S Pezen, J M Leonard, et al.
Journal of Virology|August 8, 1998
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitorA Carrillo, K D Stewart, H L Sham, et al.
Clinical Pharmacology and Therapeutics|May 20, 1998
Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavirA Hsu, G R Granneman, G Cao, et al.
Transplantation|September 1, 1983
Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantationJ E Sanders, C D Buckner, J M Leonard, et al.
The New England Journal of Medicine|December 7, 1995
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study GroupS A Danner, A Carr, J M Leonard, et al.
Science (New York, N.Y.)|December 23, 1988
Development of disease and virus recovery in transgenic mice containing HIV proviral DNAJ M Leonard, J W Abramczuk, D S Pezen, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteersA Hsu, G R Granneman, G Cao, et al.
The New England Journal of Medicine|December 7, 1995
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infectionM Markowitz, M Saag, W G Powderly, et al.
The Journal of Infectious Diseases|April 16, 1998
Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavirJ B Angel, A Kumar, K Parato, et al.
Journal of Virology|May 30, 1998
Genotypic changes in human immunodeficiency virus type 1 associated with loss of suppression of plasma viral RNA levels in subjects treated with ritonavir (Norvir) monotherapyP S Eastman, J Mittler, R Kelso, et al.
Pageof 7